Status:
COMPLETED
Exercise Capacity and Physical Activity Level in Prolactinoma Patients
Lead Sponsor:
Hacettepe University
Conditions:
Prolactinoma
Eligibility:
FEMALE
18-55 years
Brief Summary
Prolactinoma, one of the most common pituitary adenomas, is an adenoma that causes excessive prolactin (PRL) secretion. An increase in prolactin level can cause weakness, decrease in muscle mass and f...
Detailed Description
Prolactinoma is a pituitary adenoma caused by excessive prolactin secretion. More than 70% of patients are women. Many physiological conditions such as pregnancy, breastfeeding, breast stimulation, st...
Eligibility Criteria
Inclusion
- Inclusion Criteria of patients:
- Being between the ages of 18-55
- Woman
- Being diagnosed with prolactinoma
- Volunteering to participate in the study
- Exclusion Criteria of the patients :
- Patients with neurological, cognitive or orthopedic disease that will affect the measurements
- Patients with severe respiratory disease (FEV1 \< 35%; FVC \< 50%)
- Presence of acute infection
- Presence of malignancy
- Presence of dementia
- Patients who have had a cardiovascular event in the last 6 months
- Less than 50% of the ejection fraction
- Patients with uncontrolled hypertension
- Individuals with a diagnosis of uncontrolled diabetes mellitus will not be included in the study.
- Healthy group inclusion criteria:
- Being between the ages of 18-55
- Woman
- Not being diagnosed with any pituitary adenoma
- Volunteering to participate in the study
- Healthy group exclusion criteria:
- Cases with neurological, cognitive or orthopedic diseases that will affect the measurements
- Cases with severe respiratory disease (FEV1 \< 35%; FVC \< 50%)
- Presence of acute infection
- Presence of malignancy
- Presence of dementia
- Cases who have had a cardiovascular event in the last 6 months
- Less than 50% of the ejection fraction
- Patients with uncontrolled hypertension
- Cases with uncontrolled diabetes mellitus diagnosis will not be included in the study.
Exclusion
Key Trial Info
Start Date :
June 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2022
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05236829
Start Date
June 16 2021
End Date
October 15 2022
Last Update
May 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Turkey (Türkiye)